CONGRESS ABSTRACT

Left Ventricular Hypertrabeculation (LVHT) is a myocardial disorder characterized by abnormal trabeculations in the left ventricular lumen and deep intertrabecular recesses; this phenotypic trait can occur either in isolation or in association with other conditions, such as left ventricular hypertrophy, dilation, systolic/diastolic dysfunction or congenital heart defects. In recent…

Background Worldwide sudden cardiac death (SCD) remains a major cause of death, despite the recent progress in prevention and interventions of cardiac disease. Implantable  cardioverter defibrillator (ICD) is an effective weapon for SCD prevention in high risk patients with reasonable expectation of survival.However in case of transient  risk of SCD, the…

Background. Persistently reduced left ventricular ejection fraction (LVEF) is associated with an increased risk of sudden cardiac death with an indication for an implantable cardioverter-defibrillator (ICD) after 3 months of optimal medical therapy (OMT) during which it is not clear how to prevent SCD and how to distinguish patients with…

Background Nowadays a wearable cardioverter defibrillator  (WCD) is reccomended in current guidelines in patients with transient risk of sudden cardiac death (SCD). A crucial factor for the effectiveness of the WCD is adequate patient compliance. In literature patients  wore WCD with different  wearing time between first randomized trial and…

Brugada syndrome (BrS) is a hereditary arrhythmic disorder characterized by distinctive electrocardiographic (ECG) pattern, correlated with ventricular arrhythmias and sudden cardiac death in young adults. While primarily linked to a loss-of-function mutation in the SCN5A gene, acquired forms of the syndrome have been associated with various factors, including drug use. We…